Professor Bruce Taylor and Elizabeth Highton discuss how certain genetic risk variants may predict the clinical course and progression of Multiple Sclerosis.
This podcast relates to the Patient Choice paper published in the JNNP November 2016 issue and is accessible here: http://jnnp.bmj.com/content/87/11/1204.full.